We have located links that may give you full text access.
Comparative analysis of multiple techniques for developing and transferring safety performance functions.
Accident; Analysis and Prevention 2018 October 12
Safety performance functions (SPFs) are crash count prediction models that are used for identifying high crash risk locations, evaluating road safety before and after countermeasure deployment and comparing the safety of alternative site designs. The traditional method of modeling crash counts is negative binomial (NB) regression. Furthermore, the Highway Safety Manual (HSM) provides analytical tools, including NB SPFs, to assess and improve road safety. Even though the HSM's SPFs are restricted to NB models, the road safety literature is rich with a variety of different modeling techniques. Researchers have calibrated the HSM's SPFs to local conditions using a calibration method prescribed by the HSM. However, studies in which SPFs are developed and transferred to other localities are uncommon. In this paper, we develop and transfer rural divided multilane highway segment SPFs of Florida, Ohio, Illinois, Minnesota, California, Washington and North Carolina to each state. For every state, NB, zero-inflated NB, Poisson lognormal (PLN), regression tree, random forest (RF), boosting and Tobit models are developed. A hybrid model that coalesces the predictions of both the Tobit and the NB model is proposed and developed as well. All SPFs are transferred to each state and their predictive performances are evaluated to discern which model type is the most transferable. According to the transferability results, there is no single superior model type. However, the Tobit, RF, tree, NB and hybrid models demonstrate better predictive performances than those of the other methods in a considerably large proportion of transferred SPFs.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app